Unique ID issued by UMIN | UMIN000020474 |
---|---|
Receipt number | R000023653 |
Scientific Title | Circulating Serpina3 / EGFR / Adipsin levels in Japanese patients with type 2 diabetes. |
Date of disclosure of the study information | 2016/01/08 |
Last modified on | 2016/01/15 18:00:26 |
Circulating Serpina3 / EGFR / Adipsin levels in Japanese patients with type 2 diabetes.
Circulating Serpina3 / EGFR / Adipsin levels in Japanese patients with type 2 diabetes.
Circulating Serpina3 / EGFR / Adipsin levels in Japanese patients with type 2 diabetes.
Circulating Serpina3 / EGFR / Adipsin levels in Japanese patients with type 2 diabetes.
Japan |
Type 2 diabetes
Medicine in general | Endocrinology and Metabolism |
Others
NO
To determine the role of serum Serpina3 / EGFR / Adipsin in the physiological significance in patients with type 2 diabetes
Others
To determine the physiological significance
Serum Serpina3 / EGFR / Adipsin levels
The association of the serum Serpina3 / EGFR / Adipsin levels with the various metabolic parameters is analyzed in enrolled subjects.
Observational
20 | years-old | <= |
70 | years-old | > |
Male and Female
<Type 2 diabetes group>
Hospitalized Patients with type 2 diabetes who fulfilled the following criteria.
1) Age is over 20 and below 70.
2) Patients diagnosed with type 2 diabetes.
3) Having provided voluntary written consent for participation in this study.
<Control group>
Hospitalized Patients with non-type 2 diabetes who fulfilled the following criteria.
1) Age is over 20 and below 70.
2) Patients who are not diagnosed with type 2 diabetes.
3) Having provided voluntary written consent for participation in this study.
Patients corresponding to any of the following are inapplicable
<Type 2 diabetes group>
1)Patients with severe complications( liver disease, mental disorder, cancer)
2)Patients with severe ketosis or diabetic coma.
3)Patients with severe infections, perioperative status, or severe trauma
4) Patients whose baseline eGFR were <29 ml/min/1.73m^2
5)Pregnancy or lactation in women
6) Patients who are judged by an investigator to be inappropriate for this study for any other reason.
<Control group>
1)Patients with severe complications( liver disease, mental disorder, cancer)
2)Patients with severe infections, perioperative status, or severe trauma
3)Pregnancy or lactation in women
4) Patients who are judged by an investigator to be inappropriate for this study for any other reason.
80
1st name | |
Middle name | |
Last name | Yasuo Terauchi |
Yokohama City University Graduate School of Medicine
Department of Endocrinology and Metabolism
3-9 Fukuura, Kanazawa-ku, Yokohama
045-787-2800
terauchi@yokohama-cu.ac.jp
1st name | |
Middle name | |
Last name | Mayu Kyohara |
Yokohama City University Graduate School of Medicine
Department of Endocrinology and Metabolism
3-9 Fukuura, Kanazawa-ku, Yokohama
045-787-2800
kyouhara-tym@umin.ac.jp
Yokohama City University hospital
None
Self funding
NO
2016 | Year | 01 | Month | 08 | Day |
Unpublished
Open public recruiting
2015 | Year | 12 | Month | 11 | Day |
2016 | Year | 01 | Month | 08 | Day |
2017 | Year | 11 | Month | 30 | Day |
Cross-sectional study
Recruitment of Subject:
Hospitalized Patients with type 2 diabetes or non-type2 diabetes
in Yokohama City University hospital who fulfilled the inclusion/exclusion criteria.
To determine the role of serum Serpina3 / EGFR / Adipsin in the physiological significance in patients with type 2 diabetes
2016 | Year | 01 | Month | 07 | Day |
2016 | Year | 01 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023653
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |